Crowe FL, Key TJ, Allen NE, Appleby PN, Roddam A, Overvad H, Grnbaek H, Tjnneland A, Halkjaer J, Dossus L, Boeing H, Krger J, Trichopoulou A, Dilis V, Trichopoulos D, Boutron-Ruault MC, De Lauzon B, Clavel-Chapelon F, Palli D, Berrino F, Panico S, Tumino R, Sacerdote C, Bueno-de-Mesquita HB, Vrieling A, van Gils CH, Peeters PH, Gram IT, Skeie G, Lund E: The association between diet and serum concentrations of IGF-I, IGFBP-1, IGFBP-2, and IGFBP-3 in the European Prospective Investigation into Cancer and Nutrition
Orrico F, Laurance S, Lopez AC, Lefevre SD, Thomson L, Mller MN, et al
This change alone may significantly improve long-term glycemic outcomes across broader populations
Tirzepatide represents the larger expense
It comes in practical, non-waxy packaging
And am I a candidate for medication like this